President Bola Ahmed Tinubu has commended Dr Bolu Ogunyemi, a distinguished Clinical Associate Professor of Medicine at the Memorial University of Newfoundland, on his recent election as President of the Canadian Medical Association (CMA).
Celebrating the remarkable achievement with Dr Ogunyemi, a renowned dermatologist in St. John’s, Newfoundland, the President said the esteemed recognition is a testament to Dr Ogunyemi’s visionary leadership, dedication to excellence, and compassionate commitment to enhancing the welfare of others.
A statement by the Special Adviser to the President on Information and Strategy, Bayo Onanuga, expressed President Tinubu’s confidence in Dr Ogunyemi’s background in medical science and his 15 years of leadership experience.
The President added that the several years of experience have eminently prepared him for the prestigious role.
The Nigerian Leader expressed optimism that the forthcoming approval of Ogunyemi’s election at the CMA’s Annual General Meeting in May 2025 will empower him and enable him to elevate the association to even greater heights.
President Tinubu encouraged the Clinical Associate Professor to remain steadfast and focused on fulfilling his new mandate with inclusivity and respect for diverse perspectives.
He further urged Dr Ogunyemi to embrace those who vied for the position as partners in progress.
The President assured Dr Ogunyemi of the prayers and unwavering support of the Nigerian government and its people as he takes on the mantle of leadership.
Dr Bolu Ogunyemi, a Clinical Associate Professor of Medicine is also a visiting specialist in Labrador City since 2018.
A Nigerian clinical associate professor of medicine at Memorial University of Newfoundland, Dr Bolu Ogunyemi, was elected as the Canadian Medical Association’s (CMA) president-elect in an election that took place between Nov. 20th and Dec. 4th, 2024.
Pending approval at the CMA’s Annual General Meeting in May 2025, Dr Ogunyemi will assume the role of president-elect before becoming president for a one-year term in May 2026.
Comments are closed.